Mode of action and mechanisms of resistance to the unusual polyglycosylated thiopeptide antibiotic persiathiacin A
Persiathiacin A is a new natural antibiotic, active against MRSA and Mycobacterium tuberculosis. We showed it stops protein synthesis by jamming the ribosome so it cannot move along the mRNA.
Bacteria can become resistant, mostly by losing or changing a ribosomal protein called L11, but the resistant strains grow badly, which suggests they would struggle to cause disease. We also found why the bacterium that makes the antibiotic is not poisoned by it.
Read the paper → ACS Infect. Dis. 11(1), 155-163 (2025)

